Apple, Qualcomm: New Targets, Estimates

boosted through 2012, UBS said. iPhone sales continue to drive growth. Buy rating and new $495 price target. Abbott Laboratories (ABT) estimates upped at Morgan Stanley through 2012. Company is seeing better Humira sales. Overweight rating and $55 price...